MarketPulse

share pricing

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Pharvaris N.V.

Pharvaris Raises $115M to Advance Rare Disease Pipeline

Pharvaris raises $115M through 3.87M share offering at $29.68 per share to advance oral angioedema treatments; Phase 3 data expected Q3 2026.
PHVSPhase 3 clinical trialFDA approval
GlobeNewswire Inc.GlobeNewswire Inc.··Na

LifeStance Health Facilitates $285M Secondary Offering as Insiders Monetize Stakes

LifeStance Health ($LFST) prices $285M secondary offering of 35M shares at $8.15 each, with company repurchasing 6M shares to offset dilution.
LFSTsecondary offeringpublic offering